跳至主要内容
临床试验/ACTRN12616000511437
ACTRN12616000511437已完成未知

A non-blinded, randomised, controlled, superiority trial of StrataXRT 'Registered Trademark' versus 10% Glycerine (Sorbolene) cream for prophylaxis and management of radiation dermatitis in head and neck cancer patients receiving radical radiotherapy with or without concurrent systemic therapy

Queensland University of Technology0 个研究点目标入组 196 人开始时间: 2016年4月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants in this study will be patients receiving radical radiotherapy +/- concurrent chemotherapy or biotherapy for head and neck cancer at the Royal Brisbane and Women's Hospital
  • *Age >18 years
  • *Patients who have a definitive diagnosis of head and neck cancer
  • *Patients who are receiving radiotherapy (>50 Gy) either as primary treatment or postoperative treatment to their head and neck.

排除标准

  • *Patients who are unable to consent
  • *Patients with pre-existing skin rash, ulceration or open wound in the treatment area
  • *Patients with known allergic and other systemic skin diseases even not directly affecting irradiated fields.
  • *Patients with any known allergic reactions towards any ingredient of either the StrataXRT 'Registered Trademark' or the Sorbolene and failed the patch test.

研究者

相似试验